AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.650
0.00 (0.08%)
At close: Dec 20, 2024, 4:00 PM
0.611
-0.039 (-6.06%)
After-hours: Dec 20, 2024, 6:22 PM EST
AEON Biopharma Employees
AEON Biopharma had 10 employees as of December 31, 2023. The number of employees increased by 2 or 25.00% compared to the previous year.
Employees
10
Change (1Y)
2
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
$1,368,000
Market Cap
25.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 10 | 2 | 25.00% |
| Dec 31, 2022 | 8 | -12 | -60.00% |
| Dec 31, 2019 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Allurion Technologies | 504 |
| HOOKIPA Pharma | 179 |
| Adagio Medical Holdings | 85 |
| LAVA Therapeutics | 37 |
| Femasys | 34 |
| Cognition Therapeutics | 28 |
| Daré Bioscience | 26 |
| Longeveron | 24 |
AEON News
- 5 weeks ago - AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024 - GlobeNewsWire
- 4 months ago - AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan - GlobeNewsWire
- 7 months ago - AEON Biopharma Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 8 months ago - AEON Biopharma Provides Update on Development Pipeline - GlobeNewsWire
- 8 months ago - AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine - GlobeNewsWire
- 9 months ago - CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants - GlobeNewsWire